Journal article
Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer
Abstract
BackgroundStereotactic ablative radiotherapy (SABR) is a safe and effective modality in patients with liver cancer who are ineligible for other local therapies. However SABR is not current standard of practice and requires further validation. Patient reported quality of life (QOL) is key to this validation, yet no systematic reviews to date have been performed to analyse QOL following liver SABR. QOL is a critical part of therapy evaluation, …
Authors
Mutsaers A; Greenspoon J; Walker-Dilks C; Swaminath A
Journal
Radiation Oncology, Vol. 12, No. 1,
Publisher
Springer Nature
Publication Date
December 2017
DOI
10.1186/s13014-017-0818-8
ISSN
1748-717X